Loading...

PE anti-mouse/human CD44 Antibody

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7_PE_071608.jpg
C57BL/6 mouse splenocytes stained with IM7 PE
  • IM7_PE_071608.jpg
    C57BL/6 mouse splenocytes stained with IM7 PE
  • IM7_PE_human
    Human peripheral blood lymphocytes stained with IM7 PE
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
103023 25 tests 36€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103007 50 µg 45€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103024 100 tests 94€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103008 200 µg 117€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
µg sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. For µg sizes, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References

(PubMed link indicates BioLegend citation)
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  2. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  3. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  4. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  5. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  6. Shi Y, et al. 2020. Med Sci Monit. 26:e923328. PubMed
  7. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  8. Hammer A, et al. 2017. J Neuroinflammation. 10.1186/s12974-017-0954-y. PubMed
  9. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  10. MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
  11. Saenz F, et al. 2014. PLoS One. 9:97666. PubMed
  12. Shapiro MR, et al. 2020. Front Immunol. 1.972222222. PubMed
  13. Wang D, et al. 2018. Immunity. 48:659. PubMed
  14. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  15. Yang C, et al. 2022. Cancers (Basel). 14:. PubMed
  16. Byun JK, et al. 2020. Molecular Cell. 80(4):592-606.e8. PubMed
  17. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  18. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  19. Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
  20. Volpedo G, et al. 2022. NPJ Vaccines. 7:32. PubMed
  21. Davila S, et al. 2014. J Immunol. 192:4284. PubMed
  22. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  23. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  24. Trial J, et al. 2017. Basic Research in Cardiology. 10.1007/s00395-017-0623-4. PubMed
  25. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  26. Shao B, et al. 2019. J Immunol. 10.4049/jimmunol.1900680. PubMed
  27. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  28. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  29. Zhang Q, et al. 2021. Nat Commun. 12:4592. PubMed
  30. Sung SE, et al. 2021. Vet Sci. 8:. PubMed
  31. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  32. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  33. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  34. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  35. Zhuang Z, et al. 2021. J Exp Med. 218:00:00. PubMed
  36. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  37. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  38. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  39. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  40. Shao W, et al. 2010. Transplant Proc. 42:2777. PubMed
  41. Tyne A, et al. 2013. Vaccine. 31:4322. PubMed
  42. Chulpanova DS, et al. 2020. Bioengineering (Basel). 7:00. PubMed
  43. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  44. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  45. Sandborn WJ, et al. 2021. Gastroenterology. 161:1853. PubMed
  46. Du L et al. 2019. Cell metabolism. 29(6):1363-1375 . PubMed
  47. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  48. Li P, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.24. PubMed
  49. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  50. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  51. Hammer A, et al. 2016. Proc Natl Acad Sci U S A. 113(49):14109-14114. PubMed
  52. Kong T, et al. 2020. Cancer Res. 80:444. PubMed
  53. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  54. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  55. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  56. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  57. Chen Y, et al. 2010. Mol Cancer Ther. 2.374305556. PubMed
  58. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  59. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
  60. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  61. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  62. Fu X, et al. 2020. Aging (Albany NY). 12:15656. PubMed
  63. Blacking T, et al. 2011. Vet Immunol Immunopathol. 141:46. PubMed
  64. Sentman A 2011. Blood. 117:6571. PubMed
  65. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  66. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  67. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  68. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  69. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  70. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  71. Li P, et al. 2018. J Cell Mol Med. 22:3423. PubMed
  72. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  73. Zhang Z, et al. 2019. Cell Death Dis. 10:530. PubMed
  74. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  75. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  76. Biram A, et al. 2020. Bio Protoc. e3562:10. PubMed
  77. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  78. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  79. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  80. Tsuchihashi K, et al. 2022. Biochem Biophys Rep. 30:101246. PubMed
  81. Sottnik JL, et al. 2021. Cancer Res. 81:2833. PubMed
  82. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  83. Bian X, et al. 2021. Clin Transl Med. 11:e352. PubMed
  84. Yip HYK, et al. 2018. PLoS One. 3. PubMed
  85. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  86. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  87. Ge C, et al. 2020. Cell Reports. 29(13):4236-4244.e3.. PubMed
  88. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  89. Nair S, et al. 2021. JCI Insight. 6:. PubMed
  90. Ngamsri KC, et al. 2022. Cells. 11:. PubMed
  91. Xu Y, et al. 2020. Stem Cells Int. 8894449:2020. PubMed
  92. Yeung F, et al. 2020. Cell Host & Microbe. 27(5):809-822. PubMed
  93. Melhem H, et al. 2022. Mucosal Immunol. 15:443. PubMed
  94. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  95. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  96. Wang S, et al. 2021. Parasite. 28:13. PubMed
  97. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  98. Fiume G, et al. 2015. Sci Rep. 5: 13864. PubMed
  99. M H, et al. 2016. Open Bio. 6: 150208. PubMed
  100. M H, et al. 2016. Cell Transplant. 25: 811-27. PubMed
  101. Yermanos A, et al. 2020. Front Immunol. 1.143055556. PubMed
  102. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  103. Pardo E, et al. 2017. PLoS One. 12(6):e0177472. PubMed
  104. Hammer A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01922. PubMed
  105. Morley S, et al. 2008. J Immunol. 181:4696. PubMed
  106. Yue X, et al. 2021. EMBO Rep. 22:e52716. PubMed
  107. Herbst SA, et al. 2021. iScience. 24:103062. PubMed
  108. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  109. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  110. Girón-Pérez DA, et al. 2020. J Cell Sci. 133:00:00. PubMed
  111. MaruYama T, et al. 2015. J Leukoc Biol. 98: 385-393. PubMed
  112. Lee Y, et al. 2012. Nat Immunol. 13:991. PubMed
  113. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  114. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  115. Di Lorenzo A, et al. 2022. Oncoimmunology. 11:2086752. PubMed
  116. Hu J, et al. 2022. J Immunother Cancer. 10:. PubMed
  117. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  118. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  119. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  120. Korin B, et al. 2020. Sleep. :43. PubMed
  121. Lu H, et al. 2019. EBioMedicine. 40:276. PubMed
  122. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  123. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  124. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  125. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  126. Kaji T, et al. 2016. Int Immunol. 28: 267 - 282. PubMed
  127. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  128. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  129. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  130. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  131. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  132. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  133. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  134. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  135. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  136. Seo MS, et al. 2021. Vet Sci. 8:. PubMed
  137. Hung G, et al. 2022. NPJ Aging. 8:10. PubMed
  138. Velletri T, et al. 2020. Cell Death Differ. . PubMed
  139. Olguín J, et al. 2015. Microbes Infect. 17: 586-595. PubMed
  140. Bonaccorsi-Riani E, et al. 2015. PLoS One. 10: 0136106. PubMed
  141. Upasani V, et al. 2019. Front Immunol. 2.152777778. PubMed
  142. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  143. Pan Y, et al. 2021. NPJ Vaccines. 6:1. PubMed
RRID
AB_493686 (BioLegend Cat. No. 103023)
AB_312958 (BioLegend Cat. No. 103007)
AB_493687 (BioLegend Cat. No. 103024)
AB_312959 (BioLegend Cat. No. 103008)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD44 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD44 IM7 FC
Biotin anti-mouse/human CD44 IM7 FC,ICC,IHC-P
FITC anti-mouse/human CD44 IM7 FC,ICC,IHC-P
PE/Cyanine5 anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 IM7 FC,IHC-F,CyTOF®,ELISA,ICC,IHC-P,IP,CMCD,Stim
Brilliant Violet 605™ anti-mouse/human CD44 IM7 FC
PE anti-mouse/human CD44 IM7 FC
Alexa Fluor® 488 anti-mouse/human CD44 IM7 FC,ICC,IHC-P,SB
Alexa Fluor® 647 anti-mouse/human CD44 IM7 FC,ICC,SB
Pacific Blue™ anti-mouse/human CD44 IM7 FC
Alexa Fluor® 700 anti-mouse/human CD44 IM7 FC,SB
PE/Cyanine7 anti-mouse/human CD44 IM7 FC
APC/Cyanine7 anti-mouse/human CD44 IM7 FC
PerCP/Cyanine5.5 anti-mouse/human CD44 IM7 FC
PerCP anti-mouse/human CD44 IM7 FC
Brilliant Violet 421™ anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Brilliant Violet 570™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 785™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 510™ anti-mouse/human CD44 IM7 FC
Ultra-LEAF™ Purified anti-mouse/human CD44 IM7 FC,CyTOF®,ELISA,IHC,IP,CMCD,Stim
Brilliant Violet 650™ anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 (Maxpar® Ready) IM7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD44 IM7 ICC,FC,IHC-P,SB
PE/Dazzle™ 594 anti-mouse/human CD44 IM7 FC
Brilliant Violet 711™ anti-mouse/human CD44 IM7 FC
APC/Fire™ 750 anti-mouse/human CD44 IM7 FC
TotalSeq™-A0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-C0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-B0073 anti-mouse/human CD44 IM7 PG
Spark YG™ 570 anti-mouse/human CD44 IM7 FC,IHC-P
Spark YG™ 593 anti-mouse/human CD44 IM7 FC
TotalSeq™-D0073 anti-mouse/human CD44 IM7 PG
Brilliant Violet 750™ anti-mouse/human CD44 IM7 FC
PerCP/Fire™ 806 anti-mouse/human CD44 IM7 FC
Spark Red™ 718 anti-mouse/human CD44 IM7 FC
Spark Blue™ 550 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark Red™ 718 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Go To Top Version: 4    Revision Date: 10/15/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account